PODD beat EPS expectations by 24.51%
May 08, 2025, 10:32 PM
0.00%
What does PODD do
Insulet, headquartered in Acton, Massachusetts, develops and markets insulin infusion systems, including the Omnipod 5 Automated Insulin Delivery System, for insulin-dependent diabetes. The company employs 3,000 staff and went public in 2007.
Insulet (PODD) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Insulet's actual EPS was $1.01, beating the estimate of $0.81 per share, resulting in a 24.51% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.